Candiolo Cancer Institute - Gastric
Researchers at the University of Torino, Italy, aim at identifying new molecular targets in gastric cancer.
We have produced an extensive experimental resource of PDXs from primary gastro-esophageal tumors, coupled with molecular annotation including HER2 (HercepTest ), MSI, EBV status and Targeted/Whole exome sequencing. This platform enables population-level discovery of genetic and functional vulnerabilities, which can be targeted in preclinical xenotrials.
The Candiolo Cancer Institute is a member of the EurOPDX Consortium. EurOPDX is supported by the European Union's Horizon 2020 research and innovation program under the grant agreement No. 731105 EDIReX